Trial site
Humanitas Mirasole S.p.A.
- 319running trials
- 65closed trials
The trials here
What the 385 trials at this site are about, from their registry records.
- Conditions
- Lung cancer44 trials
- Ulcerative colitis23 trials
- Colorectal cancer21 trials
- Crohn's disease19 trials
- Prostate cancer19 trials
- Pancreatic cancer14 trials
- Head and neck cancer12 trials
- Liver and biliary tract cancer12 trials
- Lupus (SLE)12 trials
- Rheumatoid arthritis12 trials
- Gastric and oesophageal cancer11 trials
- Myelodysplastic syndromes11 trials
- and 71 more
- Phase
- Phase 3202 trials
- Phase 2113 trials
- Phase 122 trials
- Phase 1/221 trials
- Phase 2/316 trials
- Phase 411 trials
- Status
- Recruiting172 trials
- Active, not recruiting79 trials
- Not yet recruiting68 trials
- Completed64 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- AstraZeneca24 trials
- Merck Sharp & Dohme LLC17 trials
- Janssen Research & Development, LLC16 trials
- AstraZeneca AB14 trials
- Novartis Pharmaceuticals14 trials
- and 172 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
Recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Showing 50 of 319.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer26 recruiting
- Colorectal cancer18 recruiting
- Prostate cancer14 recruiting
- Crohn's disease12 recruiting
- Ulcerative colitis12 recruiting
- Pancreatic cancer10 recruiting
- Heart failure9 recruiting
- Liver and biliary tract cancer9 recruiting
- Lupus (SLE)9 recruiting
- Rheumatoid arthritis9 recruiting
- Fatty liver disease (MASLD/MASH)8 recruiting
- Gastric and oesophageal cancer8 recruiting
- Bladder cancer7 recruiting
- Metastatic breast cancer7 recruiting
- Multiple myeloma7 recruiting
- Myelodysplastic syndromes7 recruiting
- Acute myeloid leukaemia6 recruiting
- Asthma6 recruiting
- Bronchiectasis5 recruiting
- Follicular lymphoma5 recruiting
- Haemophilia5 recruiting
- Head and neck cancer5 recruiting
- Kidney cancer5 recruiting
- Melanoma5 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Hodgkin lymphoma4 recruiting
- Obesity4 recruiting
- Sjögren's disease4 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 recruiting
- COPD3 recruiting
- Cystic fibrosis3 recruiting
- Deep vein thrombosis and pulmonary embolism3 recruiting
- Dermatomyositis and polymyositis (myositis)3 recruiting
- Diffuse large B-cell lymphoma3 recruiting
- Mantle cell lymphoma3 recruiting
- Type 2 diabetes3 recruiting
- Atrial fibrillation2 recruiting
- Dilated cardiomyopathy2 recruiting
- Hidradenitis suppurativa2 recruiting
- High blood pressure2 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Liver cirrhosis2 recruiting
- Neuroendocrine tumours2 recruiting
- Psoriasis2 recruiting
- Stroke2 recruiting
- Triple-negative breast cancer2 recruiting
- Vitiligo2 recruiting
- Antiphospholipid syndrome1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coeliac disease1 recruiting
- Cushing's syndrome1 recruiting
- Endometrial cancer1 recruiting
- Eosinophilic oesophagitis1 recruiting
- IgA nephropathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Lichen planus1 recruiting
- Meningioma1 recruiting
- Mesothelioma1 recruiting
- Multiple sclerosis1 recruiting
- Ovarian cancer1 recruiting
- Psoriatic arthritis1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sarcoma1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
Completed
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Completed
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
Completed
Completed
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.
Completed
Completed
Completed
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Completed
Completed
Terminated
Active, not recruiting
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
Completed
Completed
Completed
A clinical study of MK-6194 for the treatment of Systemic Lupus Erythematosus (SLE) (MK-6194-006)
Terminated
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
Completed
Completed
Completed
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Completed
Active, not recruiting
Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Completed
Completed
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Recruiting
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
Active, not recruiting
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Active, not recruiting
Completed
Showing 50 of 65.
Site data: ClinicalTrials.govUpdated 15 Nov 2026